{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:50:26Z","timestamp":1784094626191,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974302"],"award-info":[{"award-number":["81974302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574303"],"award-info":[{"award-number":["82574303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303365"],"award-info":[{"award-number":["82303365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011494","name":"Baoding City Science and Technology and Intellectual Property Bureau","doi-asserted-by":"publisher","award":["2372P012"],"award-info":[{"award-number":["2372P012"]}],"id":[{"id":"10.13039\/501100011494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011494","name":"Baoding City Science and Technology and Intellectual Property Bureau","doi-asserted-by":"publisher","award":["2272P006"],"award-info":[{"award-number":["2272P006"]}],"id":[{"id":"10.13039\/501100011494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["H2021204001"],"award-info":[{"award-number":["H2021204001"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbrc.2026.153238","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:33:49Z","timestamp":1767339229000},"page":"153238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of human single-domain antibodies against influenza based on NA-targeting IgG"],"prefix":"10.1016","volume":"798","author":[{"given":"Ailing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153238_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/303035a0","article-title":"Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution","volume":"303","author":"Varghese","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153238_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313112","article-title":"Bifunctional inhibitors of influenza virus neuraminidase: molecular design of a sulfonamide linker","volume":"22","author":"Evteev","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153238_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153238_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.aay0678","article-title":"Broadly protective human antibodies that target the active site of influenza virus neuraminidase","volume":"366","author":"Stadlbauer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.153238_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-023-06136-y","article-title":"A pan-influenza antibody inhibiting neuraminidase via receptor mimicry","volume":"618","author":"Momont","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153238_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.6026\/97320630007076","article-title":"Antigenic variability in Neuraminidase protein of Influenza A\/H3N2 vaccine strains (1968 - 2009)","volume":"7","author":"Shil","year":"2011","journal-title":"Bioinformation"},{"key":"10.1016\/j.bbrc.2026.153238_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jmv.10143","article-title":"Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada","volume":"67","author":"Abed","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbrc.2026.153238_bib8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.153238_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105444","article-title":"Severe mammarenaviral disease in Guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir","volume":"208","author":"Westover","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2026.153238_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2016.06.012","article-title":"Nanobodies(R) as inhaled biotherapeutics for lung diseases","volume":"169","author":"Van Heeke","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2026.153238_bib11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.cell.2022.03.009","article-title":"Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody","volume":"185","author":"Li","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153238_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2026.153238_bib13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/nnm.13.86","article-title":"Nanobodies and their potential applications","volume":"8","author":"Hassanzadeh-Ghassabeh","year":"2013","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.bbrc.2026.153238_bib14","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1038\/s41467-024-51066-6","article-title":"Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153238_bib15","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1074\/jbc.M310752200","article-title":"Identification of formaldehyde-induced modifications in proteins: reactions with model peptides","volume":"279","author":"Metz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153238_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/341544a0","article-title":"Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli","volume":"341","author":"Ward","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153238_bib17","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1073\/pnas.0805942105","article-title":"Isolation of human monoclonal antibodies by mammalian cell display","volume":"105","author":"Beerli","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.153238_bib18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nbt1000","article-title":"Aggregation-resistant domain antibodies selected on phage by heat denaturation","volume":"22","author":"Jespers","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153238_bib19","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.ymthe.2022.04.013","article-title":"A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors","volume":"30","author":"Wu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2026.153238_bib20","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/nar\/gkt1104","article-title":"Prospective identification of parasitic sequences in phage display screens","volume":"42","author":"Matochko","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153238_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106240","article-title":"Surveillance of avian influenza viruses in Hebei Province of China from 2021 to 2023: identification of a novel reassortant H3N3","volume":"89","author":"Li","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.bbrc.2026.153238_bib22","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3389\/fimmu.2017.01802","article-title":"Single-domain antibodies as therapeutics against human viral diseases","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153238_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1729393","article-title":"Recombinant expression and functional characterization of influenza A virus neuraminidase in a mammalian cell system","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.153238_bib24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jmb.2004.02.013","article-title":"Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold","volume":"337","author":"Jespers","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153238_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.chom.2020.04.023","article-title":"Identification of human single-domain antibodies against SARS-CoV-2","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbrc.2026.153238_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.xphs.2021.08.022","article-title":"Identification of stability constraints in the particle engineering of an inhaled monoclonal antibody dried powder","volume":"111","author":"Brunaugh","year":"2022","journal-title":"J. Pharm. Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2600001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2600001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:05:33Z","timestamp":1773950733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2600001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S0006291X2600001X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153238","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of human single-domain antibodies against influenza based on NA-targeting IgG","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153238"}}